Achieving Lupus Low Disease Activity State (LLDAS-50) is associated with both reduced damage accrual and mortality in patients with Systemic Lupus Erythematosus.
To assess the impact of achieving Lupus Low Disease Activity State (LLDAS-50) on damage accrual and mortality in an inception cohort of patients with Systemic Lupus Erythematosus (SLE). We used data from the Tromsø Lupus Cohort, a longitudinal population-based study of all SLE patients in the 2 northern-most counties in Norway. LLDAS was defined as a) SLEDAI-2K ≤4, with no activity in major organ systems b) no new features of lupus disease activity c) current prednisolone (or equivalent) dose ≤7.5 mg daily, and, d) well tolerated standard maintenance doses of immunosuppressive drugs. A total of 69 patients (33.5%) spent at least half of their follow up time in LLDAS, thus achieving LLDAS-50, and these patients had both significantly better survival and lower risk of developing severe SDI over time. After correcting for age and sex, LLDAS-50 was associated with a significant reduction in risk of having severe damage (HR 0.37; 95%CI 0.19 - 0.73, p < 0.01), and also a reduction in mortality (HR 0.31; 95%CI 0.16 - 0.62, p < 0.01). Our study validates the findings of the inception cohort by demonstrating that achieving LLDAS-50 is associated with a significant reduction in severe damage, but for the first time also demonstrates a reduction in mortality. This article is protected by copyright. All rights reserved.